Global Pulmonary Hypertension Market and Competitive Landscape – 2017

Best Price Guarantee	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450495

Best Price Guarantee
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450495

Global Pulmonary Hypertension Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Pulmonary Hypertension Market and Competitive Landscape – 2017, provides comprehensive insights into Pulmonary Hypertension pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Pulmonary Hypertension market size and drug sales. This research also provides insights into Pulmonary Hypertension epidemiology and late stage pipeline.
The report is classified into twelve sections – Pulmonary Hypertension overview with definitions, symptoms, etiology, diagnosis, treatment options; Pulmonary Hypertension pipeline insights covering late stage clinical trials pipeline; Pulmonary Hypertension prevalence trends by countries; Pulmonary Hypertension market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Pulmonary Hypertension pipeline: Find out the drugs in clinical trials for Pulmonary Hypertension by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Pulmonary Hypertension epidemiology: Find out the prevalence of Pulmonary Hypertension by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Pulmonary Hypertension products: Identify key products marketed and prescribed for Pulmonary Hypertension by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Pulmonary Hypertension market size: Find out the market size for Pulmonary Hypertension drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Pulmonary Hypertension drug sales: Find out the sales of Pulmonary Hypertension drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Pulmonary Hypertension drugs sales forecast: Sales forecast for Pulmonary Hypertension drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Pulmonary Hypertension market share analysis: Find out the market shares of Pulmonary Hypertension drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Pulmonary Hypertension drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Pulmonary Hypertension market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Pulmonary Hypertension market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Pulmonary Hypertension: Disease Overview: 1.1. Pulmonary Hypertension Symptoms; 1.2. Pulmonary Hypertension Etiology; 1.3. Pulmonary Hypertension Diagnosis; 1.4. Pulmonary Hypertension Treatment Options
2. Pulmonary Hypertension Pipeline Insights: 2.1. Pulmonary Hypertension Phase 3 Clinical Trials; 2.2. Pulmonary Hypertension Phase 2 Clinical Trials; 2.3. Pulmonary Hypertension Phase 1 Clinical Trials
3. Pulmonary Hypertension Epidemiology Analysis
4. US Pulmonary Hypertension Market Insights: 4.1. Marketed Products for Pulmonary Hypertension in US; 4.2. US Pulmonary Hypertension Market Size & Forecast; 4.3. US Pulmonary Hypertension Product Sales Forecast; 4.4. US Pulmonary Hypertension Market Share Analysis
5. Germany Pulmonary Hypertension Market Insights: 5.1. Marketed Products for Pulmonary Hypertension in Germany; 5.2. Germany Pulmonary Hypertension Market Size & Forecast; 5.3. Germany Pulmonary Hypertension Product Sales Forecast; 5.4. Germany Pulmonary Hypertension Market Share Analysis
6. France Pulmonary Hypertension Market Insights: 6.1. Marketed Products for Pulmonary Hypertension in France; 6.2. France Pulmonary Hypertension Market Size & Forecast; 6.3. France Pulmonary Hypertension Product Sales Forecast; 6.4. France Pulmonary Hypertension Market Share Analysis
7. Italy Pulmonary Hypertension Market Insights: 7.1. Marketed Products for Pulmonary Hypertension in Italy; 7.2. Italy Pulmonary Hypertension Market Size & Forecast; 7.3. Italy Pulmonary Hypertension Product Sales Forecast; 7.4. Italy Pulmonary Hypertension Market Share Analysis
8. Spain Pulmonary Hypertension Market Insights: 8.1. Marketed Products for Pulmonary Hypertension in Spain; 8.2. Spain Pulmonary Hypertension Market Size & Forecast; 8.3. Spain Pulmonary Hypertension Product Sales Forecast; 8.4. Spain Pulmonary Hypertension Market Share Analysis
9. UK Pulmonary Hypertension Market Insights: 9.1. Marketed Products for Pulmonary Hypertension in UK; 9.2. UK Pulmonary Hypertension Market Size & Forecast; 9.3. UK Pulmonary Hypertension Product Sales Forecast; 9.4. UK Pulmonary Hypertension Market Share Analysis
10. Europe Pulmonary Hypertension Market Insights: 10.1. Europe Pulmonary Hypertension Market Size & Forecast; 10.2. Europe Pulmonary Hypertension Product Sales Forecast; 10.3. Europe Pulmonary Hypertension Market Share Analysis
11. Japan Pulmonary Hypertension Market Insights: 11.1. Marketed Products for Pulmonary Hypertension in Japan; 11.2. Japan Pulmonary Hypertension Market Size & Forecast; 11.3. Japan Pulmonary Hypertension Product Sales Forecast; 11.4. Japan Pulmonary Hypertension Market Share Analysis
12. Global Pulmonary Hypertension Market Insights: 12.1. Global Pulmonary Hypertension Market Size & Forecast; 12.2. Global Pulmonary Hypertension Product Sales Forecast; 12.3. Global Pulmonary Hypertension Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Pulmonary Hypertension Phase 3 Clinical Trials, Global, 2017; Table 2: Pulmonary Hypertension Phase 2 Clinical Trials, Global, 2017; Table 3: Pulmonary Hypertension Phase 1 Clinical Trials, Global, 2017; Table 4: Pulmonary Hypertension Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Pulmonary Hypertension in US, 2017; Table 6: US Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 8: US Pulmonary Hypertension Market Trends, 2012 - 2021; Table 9: Marketed Products for Pulmonary Hypertension in Germany, 2017; Table 10: Germany Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 12: Germany Pulmonary Hypertension Market Trends, 2012 - 2021; Table 13: Marketed Products for Pulmonary Hypertension in France, 2017; Table 14: France Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 16: France Pulmonary Hypertension Market Trends, 2012 - 2021; Table 17: Marketed Products for Pulmonary Hypertension in Italy, 2017; Table 18: Italy Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 20: Italy Pulmonary Hypertension Market Trends, 2012 - 2021; Table 21: Marketed Products for Pulmonary Hypertension in Spain, 2017; Table 22: Spain Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 24: Spain Pulmonary Hypertension Market Trends, 2012 - 2021; Table 25: Marketed Products for Pulmonary Hypertension in UK, 2017; Table 26: UK Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 28: UK Pulmonary Hypertension Market Trends, 2012 - 2021; Table 29: Europe Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Pulmonary Hypertension in Japan, 2017; Table 32: Japan Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Table 34: Japan Pulmonary Hypertension Market Trends, 2012 - 2021; Table 35: Global Pulmonary Hypertension Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Pulmonary Hypertension Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Pulmonary Hypertension Pipeline by Phase (%), Global, 2017; Figure 2: Pulmonary Hypertension Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 4: US Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 5: US Pulmonary Hypertension Market Share by Products (%), 2016; Figure 6: US Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 7: Germany Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 8: Germany Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 9: Germany Pulmonary Hypertension Market Share by Products (%), 2016; Figure 10: Germany Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 11: France Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 12: France Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 13: France Pulmonary Hypertension Market Share by Products (%), 2016; Figure 14: France Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 15: Italy Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 16: Italy Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 17: Italy Pulmonary Hypertension Market Share by Products (%), 2016; Figure 18: Italy Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 19: Spain Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 20: Spain Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 21: Spain Pulmonary Hypertension Market Share by Products (%), 2016; Figure 22: Spain Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 23: UK Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 24: UK Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 25: UK Pulmonary Hypertension Market Share by Products (%), 2016; Figure 26: UK Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 27: Europe Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 28: Europe Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 29: Europe Pulmonary Hypertension Market Share by Products (%), 2016; Figure 30: Europe Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 31: Japan Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 32: Japan Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 33: Japan Pulmonary Hypertension Market Share by Products (%), 2016; Figure 34: Japan Pulmonary Hypertension Market - Future Market Share (%), 2021; Figure 35: Global Pulmonary Hypertension Market Size ($mn), 2012 - 2021; Figure 36: Global Pulmonary Hypertension Product Sales ($mn), 2012 - 2021; Figure 37: Global Pulmonary Hypertension Market Share by Products (%), 2016; Figure 38: Global Pulmonary Hypertension Market - Future Market Share (%), 2021